severe gas pain glp 1 How to Get Rid of Bloating on GLP-1 Medications Potential Use of GLP-1 and

The FDA-approved brand products (Wegovy, Zepbound) are considered first-line for obesity

Por ello es necesaria la valoracin, prescripcin y supervisin de un mdico especialista

It plays a central role in: Anticipation of reward Reinforcement learning Motivation and goal-directed behavior Drive to seek energy-dense or novel stimuli Highly palatable foods strongly engage these reward pathways, which is one reason reward-driven feeding behavior is so robust in many lab subjects and research subjects

In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg

This is particularly beneficial for women struggling with obesity or weight-related health issues